Abstract:In order to study the safety and immunogenicity of recombinant Adenoviruses expressing GP5(rAd-GP5) and M protein(rAd-M) of Porcine reproductive and respiratory syndrome virus (PRRSV), Forty-seven 30-day-old post-weaning PRRSV-negative piglets were vaccinated with the viruses and bred respectively for clinical observation, virus shedding test and immune examination. The results were as following: (1) The piglets vaccinated with rAd-GP5 and rAd-M showed no significant clinical syndrome, and blood, nasal scraping, faecal samples and pen environment were all negative against PRRSV and parental Adenovirus by RT-PCR. (2) The PRRSV specific antibody titers in piglets, which vaccinated with rAd-GP5, rAd-M, rAd-GP5+M (rAd-GP5/rAd-M, V/V=1), PRRSV-Resp strain, and no inoculation, respectively, were examined at different time post immunization. The results indicated that PRRSV specific antibody could be detected by ELISA and neutralization assay 14 and 45 days post vaccination. In groups of rAd-GP5 and rAd-M, the titer of ELISA antibody were more than 1∶2400 at day 60 and 90 post vaccination, which were similar to that of piglets inoculated with PRRSV-Resp vaccine. However, the neutralizing antibody titers in the two groups of rAd-GP5 and rAd-M were less than 1∶6, which were lower than that of PRRS-Resp group, from 60 to 90 days post vaccination. Furthermore the level of ELISA antibody to PRRSV in piglets vaccinated with both rAd-GP5 and rAd-M were more than that of piglets vaccinated with single rAd-GP5 or rAd-M. (3) Following challenge with virulent strain of PRRSV-S1 at 28 days post vaccination, no significantly temperature variation of the immunized pigs was observed. The time of viremia and virus shedding in piglets vaccinated with recombinant Adenoviruses were only 2 weeks, which were shorter than that of control piglets with no vaccine. And the titers of PRRSV specific ELISA antibody and neutralizing antibody were enhanced in piglets vaccinated with rAd-GP5 or rAd-M post challenge. The results suggest that rAd-GP5 and rAd-M are safe to piglets and can elicit good protective immune responses corporately.

GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.

HSP70 Fused with GP3 and GP5 of Porcine Reproductive and Respiratory Syndrome Virus Enhanced the Immune Responses and Protective Efficacy Against Virulent PRRSV Challenge in Pigs.

Immune Responses of Pigs Immunized with a Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Porcine GM-CSF.

Enhanced Immune Responses of Mice Inoculated Recombinant Adenoviruses Expressing GP5 by Fusion with GP3 And/or GP4 of PRRS Virus

Recombinant Adenovirus Expressing GP5 and M Fusion Proteins of Porcine Reproductive and Respiratory Syndrome Virus Induce Both Humoral and Cell-Mediated Immune Responses in Mice.

Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus

Safety and Immunogenicity of the Recombinant Adenovirus Expressing the GP5 and M Protein of PRRSV in Piglets

Enhancing immunogenicity and antiviral protection of inactivated porcine reproductive and respiratory syndrome virus vaccine in piglets

Cd40 Ligand Expressed in Adenovirus Can Improve the Immunogenicity of the Gp3 and Gp5 of Porcine Reproductive and Respiratory Syndrome Virus in Swine

Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs

Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus

Evaluation of a DNA Vaccine Candidate Co-Expressing GP3 and GP5 of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) with Interferon Α/γ in Immediate and Long-Lasting Protection Against HP-PRRSV Challenge

Vaccination of Mice with ORF5 Plasmid DNA of PRRSV; Enhanced Effects by Co-Immunizing with Porcine IL-15.

Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

Construction and Characterization of A Recombinant Canine Adenovirus Expressing Gp5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus

Immunogenicity and Protective Efficacy of Recombinant Pseudorabies Virus Expressing the Two Major Membrane-Associated Proteins of Porcine Reproductive and Respiratory Syndrome Virus

Expression of Fusion Protein of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) GP3-GP5-M in PK-15 Cells

Immunogenicity of the Glycoprotein 5 Truncated Trans-Membrane Regions of Porcine Reproductive and Respiratory Syndrome Virus

Production and Immunogenicity of Chimeric Virus-Like Particles Containing Porcine Reproductive and Respiratory Syndrome Virus GP5 Protein

The mRNA Vaccine Expressing Single and Fused Structural Proteins of Porcine Reproductive and Respiratory Syndrome Induces Strong Cellular and Humoral Immune Responses in BalB/C Mice